influenza
viru
exist
contin
except
antarctica
common
subtyp
influenza
virus
isol
poultri
chicken
duck
china
virus
isol
pig
human
influenzalik
ill
hong
kong
mainland
china
demonstr
influenza
viru
could
cross
speci
barrier
expand
host
rang
bird
mammalian
recent
research
show
virus
pandem
virus
high
genet
compat
produc
higher
pathogen
reassort
experiment
condit
addit
virus
provid
six
inner
gene
contribut
evolut
virus
caus
sever
human
respiratori
infect
china
featur
indic
viru
consider
public
health
threat
thu
valuabl
reveal
pathogenesi
influenza
viru
infect
innat
immun
respons
host
virus
pathogen
invas
could
recogn
pattern
recognit
receptor
prr
result
product
interferon
type
interferon
bind
receptor
activ
jakstat
signal
pathway
result
express
hundr
interferonstimul
gene
isg
product
gene
mostli
antivir
protein
essenti
mediat
antivir
state
host
interferoninduc
transmembran
protein
ifitm
identifi
nearli
year
ago
although
function
propos
primari
role
ifitm
protein
seem
antivir
ifitm
protein
famili
small
transmembran
protein
induc
strongli
interferon
also
express
basal
sever
cell
type
line
date
three
ifitm
protein
identifi
display
broad
spectrum
antivir
activ
human
mice
especi
proven
effect
resist
influenza
viru
infect
sirnamedi
deplet
ifitm
significantli
increas
viru
titer
primari
lung
fibroblast
hela
cell
overexpress
could
improv
resist
influenza
mdck
cell
line
although
antivir
activ
ifitm
identifi
multipl
type
cell
antivir
activ
report
endotheli
cell
infect
viru
inocul
inactiv
viral
particl
gener
airway
epitheli
cell
consid
main
target
cell
influenza
virus
express
two
kind
influenza
viru
receptor
sialic
acid
receptor
evid
indic
endotheli
cell
might
play
import
role
respons
influenza
viru
infect
endotheli
cell
also
show
express
two
kind
influenza
viru
receptor
provid
potenti
possibl
influenza
viru
infect
endotheli
cell
influenza
virus
proven
directli
infect
human
lung
microvascular
endotheli
cell
replic
endotheli
cell
line
sever
studi
indic
endotheli
cell
might
sourc
cytokin
involv
lung
injuri
influenza
viru
infect
import
understand
cellular
respons
endotheli
cell
influenza
viru
infect
previou
studi
reveal
viru
could
infect
human
umbil
vein
endotheli
cell
huvec
induc
high
level
express
sever
isg
especi
microarray
result
show
viru
infect
inactiv
viral
particl
inocul
increas
express
transcript
level
viral
particl
inocul
induc
higher
level
fold
fold
induc
viru
infect
howev
level
need
quantifi
realtim
pcr
western
blot
littl
known
antivir
activ
induc
viru
viral
particl
huvec
present
studi
aim
quantifi
express
induc
viru
viral
particl
investig
antivir
state
mediat
huvec
result
show
viru
infect
viral
particl
inocul
significantli
increas
express
mrna
protein
level
protein
induc
viral
particl
inocul
significantli
enhanc
antivir
state
huvec
viru
infect
first
quantifi
express
level
huvec
induc
viru
infect
viral
particl
inocul
use
quantit
realtim
pcr
western
blot
secondli
detect
level
use
elisa
kit
thirdli
observ
effect
ha
na
express
locat
posit
inactiv
viral
particl
huvec
final
investig
antivir
respons
sirna
activ
plasmid
transfect
compar
express
pattern
endotheli
cell
epitheli
cell
experi
perform
human
epitheli
cell
time
human
umbil
vein
endotheli
cell
huvec
atcc
human
bronchu
epitheli
cell
atcc
use
detect
express
secret
madin
darbi
canin
kidney
cell
mdck
atcc
use
plaqu
assay
cell
line
cultur
dmem
gibco
supplement
fb
gibco
uml
penicillin
g
streptomycin
gibco
incub
cell
passag
seed
sixwel
plate
cultur
h
experi
viru
use
studi
complet
genom
sequenc
viru
avail
genbank
access
number
virus
propag
embryon
egg
specificpathogenfre
spf
hen
h
viru
titer
determin
plaqu
assay
previou
studi
demonstr
exogen
trypsin
requir
effici
replic
viru
huvec
thu
chloromethyl
keton
tpck
treat
trypsin
ad
medium
experi
inspect
interact
viral
particl
huvec
creat
inactiv
viral
particl
use
serva
electrophoresi
accord
previou
descript
plaqu
assay
use
evalu
whether
viral
replic
capac
complet
destroy
quantifi
level
induc
viru
viral
particl
huvec
divid
three
group
control
group
inocul
virusfre
media
viru
group
infect
viru
multipl
infect
moi
viral
particl
group
inocul
viral
particl
moi
detect
effect
ha
na
sino
biolog
mrna
express
huvec
divid
control
group
low
concentr
group
high
concentr
group
cell
control
group
inocul
free
media
cell
low
high
concentr
group
respect
treat
ha
na
rna
group
use
realtim
pcr
analysi
extract
use
trizol
reagent
invitrogen
h
treatment
cdna
synthes
use
random
hexam
superscript
iii
revers
transcriptas
kit
invitrogen
realtim
pcr
perform
cdna
rna
quantit
use
ex
taqmix
takara
bio
eva
green
biotium
gapdh
amplifi
parallel
target
gene
endogen
control
sampl
analyz
triplic
fold
chang
specif
mrna
differ
group
compar
control
group
primer
sequenc
use
follow
gapdh
f
acaacttt
ggtatcgtggaaggac
r
agggatgatgttctggagagcc
f
actgaaacgacaggggaaag
r
gaacagggaccagacgacat
cell
group
use
western
blot
analysi
collect
h
treatment
lyse
ripa
lysi
buffer
cell
signal
technolog
cell
lysat
centrifug
result
supernat
resolv
sdspolyacrylamid
gel
electrophoresi
sdspage
transfer
onto
polyvinyliden
difluorid
pvdf
membran
roch
membran
block
skim
milk
probe
monoclon
antibodi
santa
cruz
biotechnolog
sigmaaldrich
incub
peroxidas
hrp
conjug
secondari
antibodi
origen
protein
visual
use
enhanc
chemiluminesc
rel
protein
level
analyz
imag
j
softwar
elisa
assay
use
quantifi
level
supernat
group
collect
h
postinfect
analyz
elisa
kit
r
system
accord
previou
descript
cell
posit
control
group
treat
poli
c
sigma
concentr
plaqu
assay
use
detect
viru
titer
propag
egg
cell
cultur
supernat
plaqu
assay
perform
mdck
cell
describ
previous
briefli
mdck
cell
seed
plate
confluent
monolay
wash
phosphat
buffer
salin
pb
infect
viru
cell
cultur
supernat
inoculum
discard
incub
h
remain
cell
wash
pb
overlay
consist
mixtur
agaros
lonza
doublestrength
dmem
tpcktrypsin
worthington
ad
cell
incub
h
plaqu
stain
crystal
violet
count
interfer
assay
cell
transfect
control
sirna
specif
sirna
use
lipofectamin
transfect
reagent
kit
invitrogen
specif
control
sirna
use
studi
purchas
santa
cruz
biotechnolog
sirna
human
cell
pool
targetspecif
nt
sirna
design
knock
gene
express
accord
instruct
product
firstli
prepar
mixtur
sirna
lipofectamin
sirna
lipofectamin
transfect
reagent
use
optimem
media
interfer
express
cell
infect
viru
viral
particl
incub
h
cell
cover
mixtur
h
incub
interfer
effect
specif
sirna
detect
western
blot
h
postinfect
overexpress
assay
cell
transfect
control
plasmid
crispr
activ
plasmid
santa
cruz
biotechnolog
use
lipofectamin
transfect
reagent
kit
invitrogen
crisper
activ
plasmid
synergi
activ
medium
sam
transcript
activ
system
design
specif
upregul
gene
express
accord
instruct
product
firstli
prepar
mixtur
plasmid
lipofectamin
plasmid
lipofectamin
transfect
reagent
use
optimem
media
cell
cover
mixtur
h
incub
overexpress
level
detect
western
blot
h
transfect
immunofluoresc
use
locat
posit
viral
particl
cell
accord
previou
descript
huvec
directli
fix
paraformaldehyd
permeabil
triton
block
phosphatebuff
salin
pb
contain
bovin
serum
albumin
bsa
h
cell
label
antinucleoprotein
np
antibodi
aviva
system
biolog
overnight
follow
stain
fitc
conjug
antirabbit
secondari
antibodi
origen
h
imag
captur
use
olympu
fluoresc
microscopi
data
express
mean
standard
deviat
sd
statist
test
perform
use
graphpad
prism
softwar
version
statist
signific
differ
determin
use
student
ttest
oneway
analysi
varianc
anova
p
consid
statist
signific
accord
previou
microarray
result
viru
infect
inactiv
viral
particl
inocul
upregul
express
transcript
level
use
realtim
pcr
western
blot
quantifi
level
induc
viru
infect
viral
particl
inocul
huvec
result
show
viru
infect
viral
particl
inocul
increas
express
mrna
protein
level
huvec
fig
compar
viru
group
viral
particl
inocul
induc
higher
level
mrna
level
h
protein
level
h
p
anova
huvec
fig
contrast
viru
infect
induc
higher
express
mrna
level
h
h
h
p
anova
higher
level
protein
h
h
p
anova
fig
data
show
viru
infect
viral
particl
inocul
induc
differ
kinet
express
inbetween
huvec
accord
previous
describ
express
ifitm
protein
potent
induc
type
interferon
determin
whether
involv
express
induc
viru
viral
particl
treat
huvec
viru
viral
particl
moi
incub
h
supernat
group
collect
h
postinfect
elisa
assay
result
show
signific
differ
p
anova
treat
untreat
control
group
time
point
huvec
fig
b
suggest
particip
induct
huvec
howev
differ
result
observ
compar
control
group
level
significantli
upregul
h
postinfect
p
anova
viral
particl
inocul
induc
higher
level
p
anova
h
fig
addit
viru
infect
also
induc
higher
level
induc
viral
particl
inocul
fig
result
demonstr
viru
viral
particl
might
share
differ
mechan
induct
express
huvec
result
fig
show
viru
infect
viral
particl
inocul
increas
express
independ
huvec
thu
investig
whether
envelop
protein
involv
induct
express
incub
huvec
ha
na
protein
differ
concentr
supernat
group
collect
h
elisa
assay
cell
extract
realtim
pcr
analysi
result
show
level
significantli
increas
treatment
ha
na
p
anova
huvec
fig
shown
fig
mrna
level
significantli
increas
h
p
anova
huvec
result
suggest
ha
na
protein
bind
alon
suffici
induc
express
huvec
viral
particl
inocul
significantli
increas
express
independ
huvec
bind
ha
na
protein
alon
suffici
increas
level
suspect
effect
viral
particl
express
gener
insid
cell
locat
viral
particl
use
immunofluoresc
cell
inocul
viral
particl
moi
incub
h
accord
previou
descript
viral
particl
label
antinp
antibodi
fitc
conjug
secondari
antibodi
h
inocul
result
show
npposit
cell
observ
inocul
viral
particl
fig
result
indic
cellular
interact
intracellular
molecul
viral
particl
might
involv
induct
express
huvec
determin
antivir
activ
protein
induc
viru
infect
huvec
infect
viru
moi
incub
h
cell
transfect
specif
sirna
control
sirna
h
shown
fig
specif
sirna
transfect
success
knock
express
induc
viru
infect
huvec
howev
viru
titer
increas
p
ttest
compar
viru
group
control
sirna
fig
similarli
express
induc
viru
infect
also
success
interf
specif
sirna
transfect
fig
viru
titer
increas
p
ttest
compar
viru
group
control
sirna
fig
result
suggest
induc
viru
infect
mediat
antivir
respons
huvec
huvec
inocul
viral
particl
moi
incub
h
cell
transfect
sirna
h
infect
viru
result
show
sirna
transfect
knock
express
induc
viral
particl
inocul
huvec
fig
b
compar
particl
group
viru
titer
significantli
increas
p
ttest
transfect
specif
sirna
fig
contrast
viru
titer
increas
p
ttest
transfect
specif
sirna
fig
result
indic
protein
induc
viral
particl
inocul
significantli
enhanc
antivir
state
huvec
huvec
transfect
plasmid
h
infect
viru
result
show
transfect
crispr
activ
plasmid
upregul
express
huvec
fig
b
compar
control
group
viru
titer
significantli
decreas
p
ttest
transfect
crispr
activ
plasmid
fig
viru
titer
significantli
decreas
p
ttest
huvec
transfect
crispr
activ
plasmid
fig
express
isg
earli
respons
host
viru
infect
product
confer
host
antivir
state
inhibit
entri
process
replic
invad
viru
date
multipl
protein
translat
isg
valid
antivir
protein
protein
kinas
r
pkr
myxovirusresist
protein
schlafen
ifitm
protein
recent
identifi
antivir
factor
play
critic
role
intrins
interferonmedi
control
viru
infect
sinc
initi
identifi
sirna
screen
factor
restrict
influenza
viru
replic
research
reveal
inhibit
effect
ifitm
envelop
virus
affect
interact
viru
envelop
protein
endosom
lysosom
recent
studi
demonstr
deplet
sirna
increas
titer
viru
primari
lung
fibroblast
cell
hela
cell
line
overexpress
resist
viru
infect
mdck
cell
line
studi
result
show
overexpress
significantli
reduc
viru
titer
huvec
fig
present
data
reaffirm
restrict
effect
influenza
viru
infect
investig
whether
induc
viru
infect
viral
particl
inocul
mediat
antivir
respons
huvec
detect
viru
titer
huvec
transfect
specif
sirna
control
sirna
result
show
induc
viru
infect
could
enhanc
antivir
state
huvec
contrast
induc
viral
particl
inocul
significantli
enhanc
antivir
respons
huvec
fig
take
account
result
hypothes
viru
replic
preced
express
initi
infect
cell
previou
studi
demonstr
effici
restrict
influenza
viru
modestli
restrict
influenza
viru
express
pattern
ifitm
like
independ
determin
viral
tropism
previou
microarray
result
show
viru
viral
particl
induc
express
huvec
specul
might
uniqu
respons
huvec
viru
infect
viral
particl
inocul
taken
togeth
data
may
offer
insight
innat
immun
respons
endotheli
cell
influenza
viru
infect
present
studi
level
induc
viral
particl
inocul
higher
induc
viru
infect
huvec
fig
observ
differ
gener
expect
worthi
think
sens
express
upregul
viral
particl
moreov
recent
studi
indic
influenza
viru
infect
induc
express
lung
heart
liver
balbc
mice
vivo
basal
lamina
averag
thick
structur
separ
epitheli
cell
endotheli
cell
death
infect
epitheli
cell
creat
gap
releas
viru
particl
readili
access
endotheli
cell
thu
releas
viru
particl
may
stimul
antivir
respons
endotheli
cell
addit
cytokin
produc
epitheli
cell
could
activ
neighbor
endotheli
cell
influenza
viru
infect
conceiv
releas
infect
epitheli
cell
could
readili
induc
express
ifitm
protein
endotheli
cell
taken
togeth
may
consid
enhanc
antivir
state
host
stimul
respiratori
tract
inactiv
viral
particl
previou
studi
indic
viru
infect
upregul
express
type
interferon
human
pulmonari
microvascular
endotheli
cell
induc
high
level
huvec
howev
result
show
express
induc
viru
viral
particl
independ
huvec
fig
although
recent
studi
demonstr
human
mous
induc
cytokin
famili
fail
find
possibl
mechan
involv
express
thu
investig
effect
ha
na
protein
express
huvec
result
show
treatment
ha
na
could
upregul
level
fig
viru
rna
activ
cellular
antivir
respons
wide
report
present
studi
investig
effect
rna
viru
antivir
respons
endotheli
cell
howev
result
show
viru
could
infect
replic
huvec
invalid
effect
antivir
respons
huvec
result
indic
rna
viru
may
play
insignific
role
express
induc
viru
infect
viral
particl
inocul
specul
induct
express
may
depend
interact
viral
particl
cellular
factor
moreov
previou
studi
demonstr
interact
cellular
factor
envelop
glycoprotein
b
replic
defect
human
cytomegaloviru
may
induc
isg
express
verifi
whether
viral
particl
taken
cell
use
immunofluoresc
result
show
viral
particl
could
enter
huvec
fig
suggest
cellular
interact
might
involv
induct
huvec
obvious
work
need
done
explor
induct
mechan
data
present
studi
might
consider
narrow
rang
possibl
mechan
gener
human
influenza
viru
avian
influenza
viru
prefer
infect
epitheli
cell
express
sialic
acid
receptor
investig
whether
phenomena
uniqu
respons
viru
viral
particl
huvec
perform
experi
epitheli
cell
synchron
result
show
endotheli
cell
epitheli
cell
share
differ
featur
consist
previou
studi
viru
infect
viral
particl
inocul
elev
level
type
interferon
fig
addit
contrari
endotheli
cell
viru
infect
induc
higher
level
fig
data
suggest
viru
viral
particl
may
stimul
innat
immun
respons
via
differ
way
vivo
cours
studi
necessari
go
beyond
present
result
exampl
investig
need
done
reveal
precis
mechan
distinct
express
pattern
epitheli
cell
endotheli
cell
particular
whether
inactiv
viral
particl
inocul
increas
express
endotheli
cell
vivo
enhanc
antivir
state
host
result
show
inactiv
viral
particl
inocul
increas
express
mrna
protein
level
huvec
moreov
induct
express
mediat
antivir
respons
huvec
